PI
-
Wearing-off symptoms persist in the majority of patients with multiple sclerosis after switching from natalizumab to ocrelizumab
Gelissen, L. M. Y., Hogenboom, L., Toorop, A. A., Strijbis, E. M. M., van Oosten, B. W., de Jong, B. A., Killestein, J. & van Kempen, Z. L. E., 15 Dec 2025, In: Journal of the Neurological Sciences. 479, 125652.Research output: Contribution to journal › Article › Academic › peer-review
-
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy
Valk, A. M., Koers, J., Derksen, N. I. L., Hogenboom, L., van Kempen, Z., Killestein, J., Rutgers, A., Heeringa, P., Horváth, B., Kuijpers, T. W., van Ham, S. M., Brinke, A. T., van der Woude, D., Toes, R. E. M., Bos, N. A., Rispens, T., Bos, A., Kummer, L. Y., Wieske, L. & Koning, M. & 5 others, , 1 Dec 2025, In: Scientific reports. 15, 1, 14770.Research output: Contribution to journal › Article › Academic › peer-review
-
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: A multinational, individual participant-level analysis
Abdelhak, A., Bachhuber, F., Ning, K., Benkert, P., John Boscardin, W., Maleska MacEski, A., Schaedelin, S., Achtnichts, L., Finkener, S., Lalive, P. H., Uginet, M., Pot, C., du Pasquier, R., Hoepner, R., Chan, A., Gobbi, C., Zecca, C., Müller, S., Roth, P. & Granziera, C. & 56 others, , 1 Nov 2025, In: J. Neurol. Neurosurg. Psychiatry. 96, 11, p. 1046-1052 7 p., jnnp-2025-335831.Research output: Contribution to journal › Article › Academic › peer-review
- All publications